PepsiCo 10-Q 2025-09-06
Filed 2025-10-09. 8 sections, 261K characters. Original on sec.gov · Markdown · JSON
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 6, 2025 (36 weeks)
OR
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 1-1183

| PepsiCo, Inc. |
(Exact Name of Registrant as Specified in its Charter)
| North Carolina | 13-1584302 | |||||||
| (State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) | |||||||
700 Anderson Hill Road, Purchase, New York 10577
| (Address of principal executive offices and Zip Code) |
(914) 253-2000
| Registrant’s telephone number, including area code |
N/A
| (Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report) |
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
| Title of each class | Trading Symbols | Name of each exchange on which registered | ||||||||||||
| Common Stock, par value 1-2/3 cents per share | PEP | The Nasdaq Stock Market LLC | ||||||||||||
| 2.625% Senior Notes Due 2026 | PEP26 | The Nasdaq Stock Market LLC | ||||||||||||
| 0.750% Senior Notes Due 2027 | PEP27 | The Nasdaq Stock Market LLC | ||||||||||||
| 0.875% Senior Notes Due 2028 | PEP28 | The Nasdaq Stock Market LLC | ||||||||||||
| 0.500% Senior Notes Due 2028 | PEP28A | The Nasdaq Stock Market LLC | ||||||||||||
| 3.200% Senior Notes Due 2029 | PEP29 | The Nasdaq Stock Market LLC | ||||||||||||
| 1.125% Senior Notes Due 2031 | PEP31 | The Nasdaq Stock Market LLC | ||||||||||||
| 0.400% Senior Notes Due 2032 | PEP32 | The Nasdaq Stock Market LLC | ||||||||||||
| 0.750% Senior Notes Due 2033 | PEP33 | The Nasdaq Stock Market LLC | ||||||||||||
| 3.550% Senior Notes Due 2034 | PEP34 | The Nasdaq Stock Market LLC | ||||||||||||
| 3.450% Senior Notes Due 2037 | PEP37 | The Nasdaq Stock Market LLC | ||||||||||||
| 0.875% Senior Notes Due 2039 | PEP39 | The Nasdaq Stock Market LLC | ||||||||||||
| 1.050% Senior Notes Due 2050 | PEP50 | The Nasdaq Stock Market LLC | ||||||||||||
| 4.050% Senior Notes Due 2055 | PEP55 | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☒ | Accelerated filer | ☐ | ||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | ||||||||
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Number of shares of Common Stock outstanding as of October 2, 2025 was 1,367,340,122.
PepsiCo, Inc. and Subsidiaries
Table of Contents
PART I FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements.
Condensed Consolidated Statement of Income
PepsiCo, Inc. and Subsidiaries
(in millions, except per share amounts, unaudited)
| 12 Weeks Ended | 36 Weeks Ended | ||||||||||||||||||||||
| 9/6/2025 | 9/7/2024 | 9/6/2025 | 9/7/2024 | ||||||||||||||||||||
| Net Revenue | $ | 23,937 | $ | 23,319 | $ | 64,582 | $ | 64,070 | |||||||||||||||
| Cost of sales | 11,113 | 10,396 | 29,343 | 28,563 | |||||||||||||||||||
| Gross profit | 12,824 | 12,923 | 35,239 | 35,507 | |||||||||||||||||||
| Selling, general and administrative expenses | 9,122 | 9,027 | 25,305 | 24,846 | |||||||||||||||||||
| Impairment of intangible assets (see Notes 1 and 4) | 133 | 24 | 1,993 | 24 | |||||||||||||||||||
| Operating Profit | 3,569 | 3,872 | 7,941 | 10,637 | |||||||||||||||||||
| Other pension and retiree medical benefits income | 26 | 41 | 91 | 155 | |||||||||||||||||||
| Net interest expense and other | (264) | (219) | (788) | (655) | |||||||||||||||||||
| Income before income taxes | 3,331 | 3,694 | 7,244 | 10,137 | |||||||||||||||||||
| Provision for income taxes | 713 | 749 | 1,504 | 2,045 | |||||||||||||||||||
| Net income | 2,618 | 2,945 | 5,740 | 8,092 | |||||||||||||||||||
| Less: Net income attributable to noncontrolling interests | 15 | 15 | 40 | 37 | |||||||||||||||||||
| Net Income Attributable to PepsiCo | $ | 2,603 | $ | 2,930 | $ | 5,700 | $ | 8,055 | |||||||||||||||
| Net Income Attributable to PepsiCo per Common Share | |||||||||||||||||||||||
| Basic | $ | 1.90 | $ | 2.13 | $ | 4.16 | 5.86 | ||||||||||||||||
| Diluted | $ | 1.90 | $ | 2.13 | $ | 4.15 | 5.84 | ||||||||||||||||
| Weighted-average common shares outstanding | |||||||||||||||||||||||
| Basic | 1,369 | 1,373 | 1,370 | 1,374 | |||||||||||||||||||
| Diluted | 1,372 | 1,378 | 1,373 | 1,379 |
See accompanying notes to the condensed consolidated financial statements.
Condensed Consolidated Statement of Comprehensive Income
PepsiCo, Inc. and Subsidiaries
(in millions, unaudited)
| 12 Weeks Ended | 36 Weeks Ended | ||||||||||||||||||||||
| 9/6/2025 | 9/7/2024 | 9/6/2025 | 9/7/2024 | ||||||||||||||||||||
| Net income | $ | 2,618 | $ | 2,945 | $ | 5,740 | $ | 8,092 | |||||||||||||||
| Other comprehensive income/(loss), net of taxes: | |||||||||||||||||||||||
| Net currency translation adjustment | 39 | (512) | 1,436 | (961) | |||||||||||||||||||
| Net change on cash flow hedges | 23 | (24) | 27 | 21 | |||||||||||||||||||
| Net pension and retiree medical adjustments | 21 | 21 | 12 | 41 | |||||||||||||||||||
| Net change on available-for-sale debt securities and other | 410 | (351) | 540 | (219) | |||||||||||||||||||
| Total other comprehensive income/(loss), net of taxes | 493 | (866) | 2,015 | (1,118) | |||||||||||||||||||
| Comprehensive income | 3,111 | 2,079 | 7,755 | 6,974 | |||||||||||||||||||
| Less: Comprehensive income attributable to noncontrolling interests | 15 | 15 | 40 | 37 | |||||||||||||||||||
| Comprehensive Income Attributable to PepsiCo | $ | 3,096 | $ | 2,064 | $ | 7,715 | $ | 6,937 |
See accompanying notes to the condensed consolidated financial statements.
Condensed Consolidated Statement of Cash Flows
PepsiCo, Inc. and Subsidiaries
(in millions, unaudited)
| 36 Weeks Ended | |||||||||||
| 9/6/2025 | 9/7/2024 | ||||||||||
| Operating Activities | |||||||||||
| Net income | $ | 5,740 | $ | 8,092 | |||||||
| Depreciation and amortization | 2,315 | 2,118 | |||||||||
| Impairment and other charges | 1,960 | 10 | |||||||||
| Product recall-related impact | — | 184 | |||||||||
| Cash payments for product recall-related impact | (5) | (138) | |||||||||
| Operating lease right-of-use asset amortization | 489 | 438 | |||||||||
| Share-based compensation expense | 207 | 260 | |||||||||
| Restructuring and impairment charges | 567 | 415 | |||||||||
| Cash payments for restructuring charges | (554) | (284) | |||||||||
| Acquisition and divestiture-related charges | 308 | 7 | |||||||||
| Cash payments for acquisition and divestiture-related charges | (80) | (4) | |||||||||
| Pension and retiree medical plan expenses | 164 | 114 | |||||||||
| Pension and retiree medical plan contributions | (400) | (300) | |||||||||
| Deferred income taxes and other tax charges and credits | 30 | 124 | |||||||||
| Tax payments related to the Tax Cuts and Jobs Act (TCJ Act) | (772) | (579) | |||||||||
| Change in assets and liabilities: | |||||||||||
| Accounts and notes receivable | (1,747) | (1,521) | |||||||||
| Inventories | (449) | (492) | |||||||||
| Prepaid expenses and other current assets | (223) | (200) | |||||||||
| Accounts payable and other current liabilities | (1,647) | (2,312) | |||||||||
| Income taxes payable | 6 | 426 | |||||||||
| Other, net | (441) | (138) | |||||||||
| Net Cash Provided by Operating Activities | 5,468 | 6,220 | |||||||||
| Investing Activities | |||||||||||
| Capital spending | (2,499) | (2,850) | |||||||||
| Sales of property, plant and equipment | 272 | 177 | |||||||||
| Acquisitions, net of cash acqu |
Showing the first 8K of 138K characters. Open the full section
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
FINANCIAL REVIEW
Our discussion and analysis is intended to help the reader understand our results of operations and financial condition and is provided as an addition to, and should be read in connection with, our condensed consolidated financial statements and the accompanying notes. Unless otherwise noted, tabular dollars are presented in millions, except per share amounts. All per share amounts reflect common stock per share amounts, assume dilution unless otherwise noted, and are based on unrounded amounts. Percentage changes are based on unrounded amounts.
Our Critical Accounting Policies and Estimates
The critical accounting policies and estimates below should be read in conjunction with those outlined in our Recast Segment Information.
Total Marketplace Spending
We offer sales incentives and discounts through various programs to customers and consumers. Total marketplace spending includes sales incentives, discounts, advertising and other marketing activities. Sales incentives and discounts are primarily accounted for as a reduction of revenue. A number of our sales incentives, such as bottler funding to independent bottlers and customer volume rebates, are based on annual targets, and accruals are established during the year, as products are delivered, for the expected payout, which may occur after year end once reconciled and settled.
These accruals are based on contract terms and our historical experience with similar programs and require management judgment with respect to estimating customer and consumer participation and performance levels. Differences between estimated expense and actual incentive costs are normally insignificant and are recognized in earnings in the period such differences are determined. In addition, certain advertising and marketing costs are also based on annual targets and recognized during the year as incurred.
For interim reporting, our policy is to allocate our forecasted full-year sales incentives for most of our programs to each of our interim reporting periods in the same year that benefits from the programs. The allocation methodology is based on our forecasted sales incentives for the full year and the proportion of each interim period’s actual gross revenue or volume, as applicable, to our forecasted annual gross revenue or volume, as applicable. Based on our review of the forecasts at each interim period, any changes in estimates and the related allocation of sales incentives are recognized beginning in the interim period that they are identified. In addition, we apply a similar allocation methodology for interim reporting purposes for certain advertising and other marketing activities.
Income Taxes
In determining our quarterly provision for income taxes, we use an estimated annual effective tax rate which is based on our expected annual income, statutory tax rates and tax structure and transactions, including transfer pricing arrangements, available to us in the various jurisdictions in which we operate. Significant judgment is required in determining our annual tax rate and in evaluating our tax positions. Subsequent recognition, derecognition and measurement of a tax position taken in a previous period are separately recognized in the quarter in which they occur.
Our Business Risks
This Form 10-Q contains statements reflecting our views about our future performance that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (Reform Act). Statements that constitute forward-looking statements within the meaning of the Reform Act
are generally identified through the inclusion of words such as “aim,” “anticipate,” “believe,” “drive,” “estimate,” “expect,” “expressed confidence,” “forecast,” “future,” “goal,” “guidance,” “intend,” “may,” “objective,” “outlook,” “plan,” “position,” “potential,” “project,” “seek,” “should,” “strategy,” “target,” “will” or similar statements or variations of such words and other similar expressions. All statements addressing our future operating performance, and statements addressing events and developments that we expect or anticipate will occur in the future, are forward-looking statements within the meaning of the Reform Act. These forward-looking statements are based on currently available information, operating plans and projections about future events and trends. They inherently involve risks and uncertainties that could cause actual results to differ materially from those predicted in any such forward-looking statement. Such risks and uncertainties include, but are not limited to: future demand for PepsiCo’s products; damage to PepsiCo’s reputation or brand image; product recalls or other issues or concerns with respect to product quality and safety; PepsiCo’s ability to compete effectively; PepsiCo’s ability to attract, develop and maintain a highly skilled workforce or effectively manage changes in our workforce; water scarcity; changes in the retail landscape or in sales to any key customer; disruption of PepsiCo’s manufacturing operations or supply chain, including increased commodity, packaging, transportation, labor and other input costs; political, social or geopolitical conditions in the markets where PepsiCo’s products are made, manufactured, distributed or sold; PepsiCo’s ability to grow its business in developing and emerging markets; changes in economic conditions in the countries in which PepsiCo operates; changes in tariffs and global trade relations; future cyber incidents and other disruptions to our information systems; failure to successfully complete or manage strategic transactions; PepsiCo’s reliance on third-party service providers and enterprise-wide systems; climate change or measures to address climate change and other sustainability matters; strikes or work stoppages; failure to realize benefits from PepsiCo’s productivity initiatives or organizational restructurings; deterioration in estimates and underlying assumptions regarding future performance of our business or investments that can result in impairment charges; fluctuations or other changes in exchange rates; any downgrade or potential downgrade of PepsiCo’s credit ratings; imposition or proposed imposition of new or increased taxes aimed at PepsiCo’s products; imposition of limitations on the marketing or sale of PepsiCo’s products; changes in laws and regulations related to the use or disposal of plastics or other packaging materials; failure to comply with personal data protection and privacy laws; increase in income tax rates, changes in income tax laws or disagreements with tax authorities; failure to adequately protect PepsiCo’s intellectual property rights or infringement on intellectual property rights of others; failure to comply with applicable laws and regulations; potential liabilities and costs from litigation, claims, legal or regulatory proceedings, inquiries or investigations; and other risks and uncertainties including those described in “Item 1A. Risk Factors” in our 2024 Form 10-K, “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Our Business Risks,” included in our Recast Segment Information and in “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Our Business Risks” of this Form 10-Q. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.
Risks Associated with Commodities and Our Supply Chain
Many of the commodities used in the production and transportation of our products are purchased in the open market. The prices we pay for such items are subject to fluctuation, and we manage this risk through the use of fixed-price contracts and purchase orders, pr
Showing the first 8K of 98K characters. Open the full section
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
See “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Our Business Risks.” In addition, see “Item 1A. Risk Factors” in our 2024 Form 10-K and “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Our Business Risks” and Note 9 to our consolidated financial statements in our Recast Segment Information.
Item 4. Controls and Procedures.
As of the end of the period covered by this report, we carried out an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the Exchange Act). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that as of the end of the period covered by this report our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (2) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
During the 12 weeks ended September 6, 2025, we continued migrating certain of our financial processing systems to an Enterprise Resource Planning (ERP) system. These systems implementations are part of our ongoing global business transformation initiative, and we plan to continue implementing such systems throughout other parts of our businesses in phases over the next several years. In connection with these ERP implementations, we are updating and will continue to update our internal control over financial reporting, as necessary, to accommodate modifications to our business processes and accounting procedures. During the 12 weeks ended September 6, 2025, we continued implementing these systems, resulting in changes that materially affected our internal control over financial reporting. These system implementations did not have an adverse effect, nor do we expect will have an adverse effect, on our internal control over financial reporting. In addition, in connection with our 2019 multi-year productivity plan, we continue to migrate to shared business models across our operations to further simplify, harmonize and automate processes. In connection with this multi-year productivity plan and resulting business process changes, we continue to enhance the design and documentation of our internal control over financial reporting processes to maintain effective controls over our financial reporting. These business process changes have not materially affected, and we do not expect them to materially affect, our internal control over financial reporting.
Except with respect to the continued implementation of ERP systems, there have been no changes in our internal control over financial reporting during the 12 weeks ended September 6, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We will continue to assess the impact on our internal control over financial reporting as we continue to implement our ERP solution and our 2019 multi-year productivity plan.
PART II OTHER INFORMATION
ITEM 1. Legal Proceedings.
The following information should be read in conjunction with the discussion set forth under Part I, “Item 3. Legal Proceedings” in our 2024 Form 10-K and Part II, “Item 1. Legal Proceedings” in our Quarterly Report on Form 10-Q for the quarter ended March 22, 2025 and our Quarterly Report on Form 10-Q for the quarter ended June 14, 2025 (Q2 2025 Form 10-Q).
As previously disclosed, on June 20, 2024, the Mayor and City Council of Baltimore, Maryland filed a lawsuit against PepsiCo, Inc., Frito-Lay, Inc., Frito-Lay North America, Inc., and several other unrelated parties asserting claims for public nuisance, deceptive acts or practices in the conduct of business, and other related claims based on allegations that the defendants’ conduct allegedly resulted in plastic pollution in Baltimore (the Baltimore Matter). On July 21, 2025, the Circuit Court for Baltimore City, Maryland dismissed with prejudice all claims except for public nuisance. The court did not opine on the public nuisance claim and stayed the case pending a decision in three cases unrelated to PepsiCo that are before the Maryland Supreme Court. Please refer to Part I, “Item 3. Legal Proceedings” in our 2024 Form 10-K for additional information.
In addition, we and our subsidiaries are party to a variety of litigation, claims, legal or regulatory proceedings, inquiries and investigations. While the results of the NYS Matter and Los Angeles Matters (each, as defined in our 2024 Form 10-K), the Baltimore Matter, the USVI Matter (as defined in the Q2 2025 Form 10-Q) and each such other litigation, claim, legal or regulatory proceeding, inquiry and investigation cannot be predicted with certainty, management believes that the final outcome of the foregoing is not expected to have a material adverse effect on our financial condition, results of operations or cash flows. See also “Item 1. Business – Regulatory Matters” and “Item 1A. Risk Factors” in our 2024 Form 10-K.
Item 1A. Risk Factors.
There have been no material changes with respect to the risk factors disclosed in our 2024 Form 10-K.
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds.
A summary of our common stock repurchases (in millions, except average price per share) during the 12 weeks ended September 6, 2025 is set forth in the table below.
Issuer Purchases of Common Stock
| Period | Total Number of Shares Repurchased**(a)** | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs | ||||||||||||||||||||||
| 6/14/2025 | $ | 6,003 | ||||||||||||||||||||||||
| 6/15/2025 - 7/12/2025 | 0.7 | $ | 131.62 | 0.7 | (93) | |||||||||||||||||||||
| 5,910 | ||||||||||||||||||||||||||
| 7/13/2025 - 8/9/2025 | 0.5 | $ | 140.01 | 0.5 | (74) | |||||||||||||||||||||
| 5,836 | ||||||||||||||||||||||||||
| 8/10/2025 - 9/6/2025 | 0.7 | $ | 148.35 | 0.7 | (96) | |||||||||||||||||||||
| Total | 1.9 | $ | 139.75 | 1.9 | $ | 5,740 |
(a)All shares were repurchased in open market transactions pursuant to the $10 billion repurchase program authorized by our Board and publicly announced on February 10, 2022, which commenced on February 11, 2022 and will expire on February 28, 2026. Shares repurchased under this program may be repurchased in open market transactions, in privately negotiated transactions, in accelerated stock repurchase transactions or otherwise.
Item 5. Other Information.
During the 12 weeks ended September 6, 2025, none of our directors or executive officers adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” as such terms are defined under Item 408 of Regulation S-K.
ITEM 6. Exhibits.
| See “Index to Exhibits” on page 55. |
INDEX TO EXHIBITS
Item 6. Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| PepsiCo, Inc. | |||||||||||
| (Registrant) | |||||||||||
| Date: | October 8, 2025 | /s/ Christine E. Tammara | |||||||||
| Christine E. Tammara | |||||||||||
| Senior Vice President and Controller | |||||||||||
| (Principal Accounting Officer) | |||||||||||
| Date: | October 8, 2025 | /s/ David Flavell | |||||||||
| David Flavell | |||||||||||
| Executive Vice President, General Counsel and Corporate Secretary | |||||||||||
| (Duly Authorized Officer) |